Spark Biomedical News

Press Releases

Clinical trial to test wearable device as treatment for chronic pain, opioid withdrawalRead MoreRead More
Feinstein Institutes for Medical Research and Spark Biomedical, Inc. advance bioelectric medicine designed to stem excessive blood lossRead MoreRead More
Battelle and Spark Biomedical join forces to advance bioelectric treatment solutions for opioid use disorderRead MoreRead More
NOWS Clinical Trial Phase IIRead MoreRead More
Long-Term Addiction Clinical TrialRead MoreRead More
Spark Biomedical, Inc Enlists Expertise of Eric Hargan and The Hargan GroupRead MoreRead More
Sierra Tucson Combats Opioid Withdrawal Using Groundbreaking Wearable Neurostimulation TherapyRead MoreRead More
Bux Pain Management Treats First Commercial Patient in the Nation Using Spark Biomedical’s Sparrow Therapy SystemRead MoreRead More
Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in AdultsRead MoreRead More
Spark Biomedical Receives FDA Breakthrough Device Designation for Infant Transcutaneous Auricular Neurostimulation (tAN™) Device, The Roo™ SystemRead MoreRead More